Rite Aid 1Q Loss Narrows On Improved Comp Sales, Margins

Date : 06/21/2012 @ 8:05AM
Source : Dow Jones News
Stock : Walgreen Co. (WAG)
Quote : 76.05  0.0 (0.00%) @ 2:05AM

Rite Aid 1Q Loss Narrows On Improved Comp Sales, Margins

Rite Aid (NYSE:RAD)
Historical Stock Chart

5 Years : From Jan 2013 to Jan 2018

Click Here for more Rite Aid Charts.
   By Chelsea Stevenson 

Rite Aid Corp.'s (RAD) fiscal first-quarter loss narrowed as the drug-store company saw a continued increase in same-store sales and improved margins.

Rite Aid narrowed its outlook for the year, pointing to the impact of new generic introductions on it same-store sales. It now expects a loss of 13 cents to 29 cents a share, on revenue between $25.3 billion and $25.7 billion, from its April forecast of a loss of 13 cents to 31 cents on revenue of $25.4 billion to $25.8 billion. The company adjusted its same-store sales to be between a 0.5% decrease and a 1% increase, compared with its previous estimate of a 1.5% increase.

The No. 3 U.S. drug-store chain behind Walgreen Co. (WAG) and CVS Caremark Corp. (CVS) has posted losses since its 2007 acquisition of the Brooks and Eckerd chains that saddled it with debt just before consumers reduced spending. Still, the latest period marked the company's 6th consecutive quarter reporting an increase in same-store sales, with 2.5% growth. Front-end sales rose 2.7%, while pharmacy sales climbed 2.4%.

The number of prescriptions filled in same stores increased 3%, benefiting from the dispute between Walgreen and Express Scripts Holding Co. (ESRX). Analysts have expected Rite Aid and CVS to gain market share as a result of the Express Scripts exit from Walgreen's network.

In the latest quarter Rite Aid remodeled 143 stores, many of which now have more clinical pharmacy services; the company ended the quarter with a total of 4,652 stores.

For the quarter ended June 2, Rite Aid recorded a loss of $28.1 million, or three cents a share, from the year-ago loss of $63.1 million, or seven cents a share. The latest quarter included a $17.8 million debt modification charge from refinancing, among other things.

Revenue grew 1.2% to $6.47 billion as higher same-store sales helped offset store closings.

Analysts polled by Thomson Reuters most recently projected a loss of four cents on revenue of $6.43 billion.

Gross margin rose to 27% from 26.5%.

On Tuesday, rival Walgreen reported its fiscal third-quarter earnings fell 11% as the drug store chain watched sales continue to decline.

Rite-Aid shares closed Wednesday at $1.17 and were inactive premarket. The stock is off 37% in the last three months.

Write to Chelsea Stevenson at chelsea.stevenson@dowjones.com

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.